Advice

following an abbreviated submission:

colecalciferol tablets (Desunin 800 IU®) is accepted for use within NHS Scotland.

Indication under review: prevention and treatment of vitamin D deficiency in adults and adolescents. In addition to specific osteoporosis treatment of patients who are at risk of vitamin D deficiency, supplemental calcium should be considered.

The therapeutic use and safety profile of colecalciferol as a treatment for vitamin D deficiency and as an adjunctive treatment in osteoporosis is well established. There are no comparative data for colecalciferol (Desunin®). It is the same cost as another vitamin D preparation.

Download detailed advice40KB (PDF)

Download

Medicine details

Medicine name:
colecalciferol (Desunin)
SMC ID:
840/13
Indication:
For the prevention and treatment of vitamin D deficiency in adults and adolescents.
Pharmaceutical company
Meda Pharmaceuticals Ltd
BNF chapter
Nutrition and blood
Submission type
Abbreviated
Status
Accepted
Date advice published
11 February 2013